However, according to literature data, higher levels of ER expression are usually considered as a positive prognostic factor (37) for recurrence but, meantime, patients with ER-positive breast cancer maintain a significant recurrence rate during extended follow-up (38). Here, ESR1 is linked to breast carcinoma.